{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:43:44Z","timestamp":1787229824197,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10151-019-02024-8","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T12:03:11Z","timestamp":1562587391000},"page":"613-623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Mesenchymal stem-cell therapy for perianal fistulas in Crohn\u2019s disease: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"23","author":[{"given":"F.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"key":"2024_CR1","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1053\/gast.2002.32362","volume":"122","author":"DA Schwartz","year":"2002","unstructured":"Schwartz DA, Loftus EV Jr, Tremaine WJ et al (2002) The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota. Gastroenterology 122:875\u2013880","journal-title":"Gastroenterology"},{"key":"2024_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/gut.21.6.525","volume":"21","author":"G Hellers","year":"1980","unstructured":"Hellers G, Bergstrand O, Ewerth S, Holmstr\u00f6m B (1980) Occurrence and outcome after primary treatment of anal fistulae in Crohn\u2019s disease. Gut 21:525\u2013527","journal-title":"Gut"},{"key":"2024_CR3","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/j.1365-2036.2005.02670.x","volume":"22","author":"E Dom\u00e8nech","year":"2005","unstructured":"Dom\u00e8nech E, Hinojosa J, Nos P et al (2005) Clinical evolution of luminal and perianal Crohn\u2019s disease after inducing remission with infliximab: how long should patients be treated? Aliment Pharmacol Ther 22:1107\u20131113","journal-title":"Aliment Pharmacol Ther"},{"key":"2024_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","volume":"4","author":"G Van Assche","year":"2010","unstructured":"Van Assche G, Dignass A, Reinisch W et al (2010) The second European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease: special situations. J Crohns Colitis 4:63\u2013101","journal-title":"J Crohns Colitis"},{"key":"2024_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1053\/j.gastro.2006.05.036","volume":"131","author":"L Beaugerie","year":"2006","unstructured":"Beaugerie L, Seksik P, Nion-Larmurier I et al (2006) Predictors of Crohn\u2019s disease. Gastroenterology 131:334\u2013335","journal-title":"Gastroenterology"},{"key":"2024_CR6","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","volume":"105","author":"XX Jiang","year":"2005","unstructured":"Jiang XX, Zhang Y, Liu B et al (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte derived dendritic cells. Blood 105:4120\u20134126","journal-title":"Blood"},{"key":"2024_CR7","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","volume":"105","author":"S Beyth","year":"2005","unstructured":"Beyth S, Borovsky Z, Mevorach D et al (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214\u20132219","journal-title":"Blood"},{"key":"2024_CR8","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","volume":"113","author":"GM Spaggiari","year":"2009","unstructured":"Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L (2009) MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113:6576\u20136583","journal-title":"Blood"},{"key":"2024_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3324\/haematol.2012.078055","volume":"98","author":"SM Melief","year":"2013","unstructured":"Melief SM, Geutskens SB, Fibbe WE, Roelofs H (2013) Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6. Haematologica 98:888\u2013895","journal-title":"Haematologica"},{"key":"2024_CR10","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/stem.1432","volume":"31","author":"SM Melief","year":"2013","unstructured":"Melief SM, Schrama E, Brugman MH et al (2013) Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells 31:1980\u20131991","journal-title":"Stem Cells"},{"key":"2024_CR11","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535","journal-title":"BMJ"},{"key":"2024_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/jrsm.38","volume":"2","author":"J Shuster","year":"2011","unstructured":"Shuster J (2011) Review: Cochrane handbook for systematic reviews for interventions, Version 5.1.0, published 3\/2011. Julian P.T. Higgins and Sally Green, Editors. Res Synth Methods 2:126\u2013130","journal-title":"Res Synth Methods"},{"key":"2024_CR13","volume-title":"Meta: general package for meta-analysis. R Package Version 4.1-0","author":"G Schwarzer","year":"2015","unstructured":"Schwarzer G (2015) Meta: general package for meta-analysis. R Package Version 4.1-0. R Foundation, Vienna"},{"key":"2024_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1214\/aoms\/1177729756","volume":"21","author":"MF Freeman","year":"1950","unstructured":"Freeman MF, Tukey JW (1950) Transformations related to the angular and the square root. Ann Math Stat 21:607\u2013611","journal-title":"Ann Math Stat"},{"key":"2024_CR15","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","volume":"48","author":"D Garcia-Olmo","year":"2005","unstructured":"Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA (2005) A phase I clinical trial of the treatment of Crohn\u2019s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48:1416\u20131423","journal-title":"Dis Colon Rectum"},{"key":"2024_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","volume":"52","author":"D Garcia-Olmo","year":"2009","unstructured":"Garcia-Olmo D, Herreros D, Pascual I et al (2009) Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52:79\u201386","journal-title":"Dis Colon Rectum"},{"key":"2024_CR17","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1136\/gut.2010.214841","volume":"60","author":"R Ciccocioppo","year":"2011","unstructured":"Ciccocioppo R, Bernardo ME, Sgarella A et al (2011) Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn\u2019s disease. Gut 60:788\u2013798","journal-title":"Gut"},{"key":"2024_CR18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00384-011-1350-1","volume":"27","author":"H Guadalajara","year":"2012","unstructured":"Guadalajara H, Herreros D, De-La-Quintana P, Trebol J, GarciaArranz M, Garcia-Olmo D (2012) Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis 27:595\u2013600","journal-title":"Int J Colorectal Dis"},{"key":"2024_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00384-012-1581-9","volume":"28","author":"F de la Portilla","year":"2013","unstructured":"de la Portilla F, Alba F, Garcia-Olmo D, Herrerias JM, Gonzalez FX, Galindo A (2013) Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn\u2019s disease: results from a multicenter phase I\/IIa clinical trial. Int J Colorectal Dis 28:313\u2013323","journal-title":"Int J Colorectal Dis"},{"key":"2024_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3727\/096368912X656045","volume":"22","author":"YB Cho","year":"2013","unstructured":"Cho YB, Lee WY, Park KJ, Kim M, Yoo HW, Yu CS (2013) Autologous adipose tissue-derived stem cells for the treatment of Crohn\u2019s fistula: a phase I clinical study. Cell Transpl 22:279\u2013285","journal-title":"Cell Transpl"},{"key":"2024_CR21","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1002\/stem.1357","volume":"31","author":"WY Lee","year":"2013","unstructured":"Lee WY, Park KJ, Cho YB et al (2013) Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn\u2019s fistula. Stem Cells (Dayton, Ohio) 31:2575\u20132581","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"2024_CR22","doi-asserted-by":"publisher","first-page":"532","DOI":"10.5966\/sctm.2014-0199","volume":"4","author":"YB Cho","year":"2015","unstructured":"Cho YB, Park KJ, Yoon SN et al (2015) Long-term results of adipose-derived stem cell therapy for the treatment of Crohn\u2019s fistula. Stem Cells Transl Med 4:532\u2013537","journal-title":"Stem Cells Transl Med"},{"issue":"918\u201327","key":"2024_CR23","first-page":"e6","volume":"149","author":"I Molendijk","year":"2015","unstructured":"Molendijk I, Bonsing BA, Roelofs H et al (2015) Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology 149(918\u201327):e6","journal-title":"Gastroenterology"},{"key":"2024_CR24","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Panes","year":"2016","unstructured":"Panes J, Garcia-Olmo D, Van Assche G et al (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. Lancet (London, England) 388:1281\u20131290","journal-title":"Lancet (London, England)"},{"key":"2024_CR25","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/codi.13223","volume":"18","author":"KJ Park","year":"2016","unstructured":"Park KJ, Ryoo SB, Kim JS et al (2016) Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn\u2019s disease: a pilot clinical trial. Colorectal Dis 18:468\u2013476","journal-title":"Colorectal Dis"},{"key":"2024_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.gastro.2017.04.001","volume":"153","author":"AB Dietz","year":"2017","unstructured":"Dietz AB, Dozois EJ, Fletcher JG et al (2017) Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology 153:59\u201362.e2","journal-title":"Gastroenterology"},{"key":"2024_CR27","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","volume":"154","author":"J Pan\u00e9s","year":"2018","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G et al (2018) Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology 154:1334\u20131342.e4","journal-title":"Gastroenterology"},{"key":"2024_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.crad.2008.08.006","volume":"64","author":"R Sinha","year":"2009","unstructured":"Sinha R, Murphy P, Hawker P, Sanders S, Rajesh A, Verma R (2009) Role of MRI in Crohn\u2019s disease. Clin Radiol 64:341\u2013352","journal-title":"Clin Radiol"},{"key":"2024_CR29","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.stem.2012.08.013","volume":"11","author":"G Ren","year":"2012","unstructured":"Ren G, Zhao X, Wang Y et al (2012) CCR29-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNF\u03b1. Cell Stem Cell 11:812\u2013824","journal-title":"Cell Stem Cell"},{"key":"2024_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4132\/KoreanJPathol.2014.48.3.217","volume":"48","author":"B Song","year":"2014","unstructured":"Song B, Kim B, Choi SH et al (2014) Mesenchymal stromal cells promote tumor progression in fibrosarcoma and gastric cancer cells. Korean J Pathol 48:217\u2013224","journal-title":"Korean J Pathol"},{"key":"2024_CR31","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1097\/MIB.0000000000000543","volume":"21","author":"M Dave","year":"2015","unstructured":"Dave M, Mehta K, Luther J, Baruah A, Dietz AB, Faubion WA Jr (2015) Mesenchymal stem cell therapy for inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis 21:2696\u20132707","journal-title":"Inflamm Bowel Dis"},{"key":"2024_CR32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10620-017-4453-x","volume":"62","author":"Y Cao","year":"2017","unstructured":"Cao Y, Ding Z, Han C, Shi H, Cui L, Lin R (2017) Efficacy of mesenchymal stromal cells for fistula treatment of crohn\u2019s disease: a systematic review and meta-analysis. Dig Dis Sci 62:851\u2013860","journal-title":"Dig Dis Sci"},{"key":"2024_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13287-017-0570-x","volume":"8","author":"Y Qiu","year":"2017","unstructured":"Qiu Y, Li MY, Feng T et al (2017) Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn\u2019s disease. Stem Cell Res Ther 8:136","journal-title":"Stem Cell Res Ther"},{"key":"2024_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/DCR.0000000000001093","volume":"61","author":"AL Lightner","year":"2018","unstructured":"Lightner AL, Wang Z, Zubair AC, Dozois EJ (2018) A systematic review and meta-analysis of mesenchymal stem cell injections for the treatment of perianal Crohn\u2019s disease: progress made and future directions. Dis Colon Rectum 61:629\u2013640","journal-title":"Dis Colon Rectum"},{"key":"2024_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s10151-019-01994-z","author":"S Choi","year":"2019","unstructured":"Choi S, Jeon BG, Chae G, Lee SJ (2019) The clinical efficacy of stem cell therapy for complex perianal fistulas: a meta-analysis. Tech Coloproctol. \n                    https:\/\/doi.org\/10.1007\/s10151-019-01994-z","journal-title":"Tech Coloproctol"},{"key":"2024_CR36","doi-asserted-by":"publisher","first-page":"e5846","DOI":"10.1371\/journal.pone.0005846","volume":"4","author":"W Wagner","year":"2009","unstructured":"Wagner W, Bork S, Horn P et al (2009) Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 4:e5846","journal-title":"PLoS One"},{"key":"2024_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.imlet.2009.07.010","volume":"126","author":"E Ivanova-Todorova","year":"2009","unstructured":"Ivanova-Todorova E, Bochev I, Mourdjeva M et al (2009) Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells. Immunol Lett 126:37\u201342","journal-title":"Immunol Lett"},{"key":"2024_CR38","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3109\/14653249.2011.597379","volume":"13","author":"M Duijvestein","year":"2011","unstructured":"Duijvestein M, Molendijk I, Roelofs H et al (2011) Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease. Cytotherapy 13:1066\u20131073","journal-title":"Cytotherapy"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-019-02024-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10151-019-02024-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-019-02024-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T23:36:00Z","timestamp":1594078560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10151-019-02024-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2024"],"URL":"https:\/\/doi.org\/10.1007\/s10151-019-02024-8","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"value":"1123-6337","type":"print"},{"value":"1128-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"10 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present paper as a review of the literature was exempt from approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this review of literature, informed consent was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}